Qilang Xiang

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 4

Top Topics

Monoclonal Antibody

Amyotrophic Lateral Sclerosis

Top Venues

BMC endocrine disorders

Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

Qilang Xiang, Mengling Yang, Wenxuan Luo, Yuzi Cao, Shiquan Shuai, Xin Wei, Anji Xiong
Combined glucocorticoids and cyclophosphamide in the treatment of Graves' ophthalmopathy: a systematic review and meta-analysis. BMC endocrine disorders 24 (1) (2024)
Qilang Xiang, Mengling Yang, Wenxuan Luo, Yuzi Cao, Shiquan Shuai, Xin Wei, Anji Xiong
Combined glucocorticoids and cyclophosphamide in the treatment of Graves' ophthalmopathy: a systematic review and meta-analysis. BMC endocrine disorders 24 (1) (2024)
Qilang Xiang, Mengling Yang, Wenxuan Luo, Yuzi Cao, Shiquan Shuai, Xin Wei, Anji Xiong
Combined glucocorticoids and cyclophosphamide in the treatment of Graves' ophthalmopathy: a systematic review and meta-analysis. BMC endocrine disorders 24 (1) (2024)
Anji Xiong, Qilang Xiang, Yuzi Cao, Shiquan Shuai
Cyclophosphamide: a Therapeutic Option for Amyotrophic Lateral Sclerosis. Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology (2021)